Robert Dee Etherington
Directeur Général chez CLENE INC.
Fortune : 32 726 $ au 30/04/2024
Postes actifs de Robert Dee Etherington
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CLENE INC. | Directeur/Membre du Conseil | 01/01/2020 | - |
| Directeur Général | 01/04/2013 | - | |
| President | 01/04/2013 | - | |
| BioUtah | Directeur/Membre du Conseil | 01/06/2016 | - |
Clene Nanomedicine, Inc.
 Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Directeur/Membre du Conseil | - | - |
| Directeur Général | 01/04/2013 | - | |
| President | 01/04/2013 | - | |
| Corsair LLC | Directeur/Membre du Conseil | 01/03/2018 | - |
Historique de carrière de Robert Dee Etherington
Anciens postes connus de Robert Dee Etherington
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Actelion Pharmaceuticals Ltd.
 Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Ltd. is a Swiss company that develops and distributes molecular weight drugs. The company is based in Allschwil, Switzerland. | Sales & Marketing | 01/09/2000 | 01/03/2013 |
Formation de Robert Dee Etherington
| Brigham Young University | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 6 |
| Suisse | 2 |
Opérationnelle
| Director/Board Member | 4 |
| Chief Executive Officer | 2 |
| President | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CLENE INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
| BioUtah | |
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Health Technology |
Actelion Pharmaceuticals Ltd.
Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Ltd. is a Swiss company that develops and distributes molecular weight drugs. The company is based in Allschwil, Switzerland. | Health Technology |
| Corsair LLC |
- Bourse
- Insiders
- Robert Dee Etherington
- Expérience